Product information

Current status:

Cancelled Post Market

Current status date:

2009-02-23

Original market date: ^{See footnote 1}

1997-12-15

Product name:

EMINASE 30 UNITS

DIN:

02229390 Electronic product monograph is not available

Company:

WELLSPRING PHARMACEUTICAL CANADA CORP
600 1741 Lower Water St
Halifax
Nova Scotia
Canada B3J 0J2

Class:

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Schedule D

American Hospital Formulary Service (AHFS): ^{See footnote 3}

20:12.20 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

B01AD03 ANISTREPLASE

Active ingredient group (AIG) number:^{See footnote5}

0122566002